Viale P.; Furlanut M.; Scudeller L.; Pavan F.; Negri C.; Crapis M.; Zamparini E.; Zuiani C.; Cristini F.; Pea F., Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2009, 33, pp. 379 - 382 [Scientific article]
Pea F; Furlanut M; Viale P, What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice?, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2009, 53, pp. 3608 - 3609 [Comment or similar]
Pea F; Furlanut M, Chapter 17 - General considerations in cardiothoracic critical care: importance of pharmacokinetics, in: Core topics in cardiothoracic critical care, USA, Cambridge University Press, 2008, pp. 123 - 126 [Legal Commentary]
Pea F.; Pavan F.; Furlanut M., Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients, «CLINICAL PHARMACOKINETICS», 2008, 47, pp. 449 - 462 [Scientific article]
Pea, F; Tavio, M; Pavan, F; Londero, A; Bresadolo, V; Adani, GL; Furlanut, M; Viale, P, Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients, «ANTIVIRAL THERAPY», 2008, 13, pp. 739 - 742 [Scientific article]
Pea, Federico, [Mutant Prevention Concentration: is it significant in the clinical practice?], «LE INFEZIONI IN MEDICINA», 2008, 16, pp. 12 - 23 [Scientific article]
Pea F.; Baccarani U.; Tavio M.; Cojutti P.; Adani G.L.; Londero A.; Baraldo M.; Franceschi L.; Furlanut M.; Viale P., Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient, «THE ANNALS OF PHARMACOTHERAPY», 2008, 42, pp. 1711 - 1716 [Scientific article]
Pea F.; Viale P., Should the currently recommended twice-daily dosing still be considered the most appropriate regimen for treating MRSA ventilator-associated pneumonia with vancomycin?, «CLINICAL PHARMACOKINETICS», 2008, 47, pp. 147 - 152 [Scientific article]
Viale P; Pea F, General pharmacological considerations and dose adjustment in antibiotic therapy for HAP., in: Nosocomial penumonia: strategies for management., CHIRCHESTER, John Wiley & sons, 2007, pp. 173 - 190 [Chapter or essay]
Viale P.; Furlanut M.; Cristini F.; Cadeo B.; Pavan F.; Pea F., Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis, «DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE», 2007, 58, pp. 137 - 139 [Scientific article]
Kemal Agbaht Amalia Alcon Antonio Anzueto Elie Azoulay Emilio Bouza Almudena Burillo Jean Chastre Jose' M. Cisneros-HerrerosAlain Combes Sandra De Miranda George Dimopoulos Neus Fabregas Miguel Gallego Jose' Garnacho-Montero; VIALE, Pierluigi; PEA, Federico, Nosocomial Pneumonia: Strategies for Managment, in: Nosocomial Pneumonia Strategies for Management, GBR, John Wiley and Sons, Ltd, 2007, pp. 173 - 189 [Legal Commentary]
Pea F.; Marioni G.; Pavan F.; Staffieri C.; Bottin R.; Staffieri A.; Furlanut M., Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose, «PHARMACOLOGICAL RESEARCH», 2007, 55, pp. 38 - 41 [Scientific article]
Pea F; Viale P, Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections., «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2007, 5, pp. 255 - 270 [Scientific article]
PEA F; VIALE P; PAVAN F; FURLANUT, Mario; PEA, Federico, Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy, «CLINICAL PHARMACOKINETICS», 2007, 46, pp. 997 - 1038 [Scientific article]
Viale P.; Pea F., What does it mean: Appropriate therapy for methicillin-resistant Staphylococcus aureus? [17], «CRITICAL CARE MEDICINE», 2007, 35, pp. 991 - 991 [Comment or similar]
